As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals ...

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...

Eli Lilly and Novo Nordisk are likely to introduce its popular injectable drugs semaglutide and tirzepatide in India in 2025. With one of the semaglutide patents set to expire in 2026, several Indian ...

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

“We aim to launch Tirzepatide in India by 2025 after obtaining ... It has been likened to the widely popular diabetes drug Ozempic (generic name: semaglutide), which has become a global ...

Just like you might choose a more affordable generic option over a more expensive ... MyStart provides bioidentical versions of Semaglutide and Tirzepatide that meet rigorous safety and efficacy ...

Something compounded tirzepatide is not? Generic tirzepatide. There’s currently no generic version of Mounjaro or Zepbound. No, compounded tirzepatide isn’t the same as Mounjaro — but it’s ...

"Generic drugs provide additional treatment ... including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Liraglutide is expected to expand access for people managing type ...